Stock market
The stock market is seeing a decline today. The market’s major index Sensex has broken about 600 points till the news is written. Amid the decline in the domestic stock market, the shares of Alembic Pharmaceuticals have given bumper returns to investors. The stock ran around 14 percent in a single day. Let us tell you the details of the share.
So the share is running
The stock of Alembic Pharmaceuticals Ltd jumped 13.61% on Monday to reach 1,104.10 high. The reason behind this is a major approval from USFDA. The company has received the final approval in two strength 20 mg/10 ml and 50 mg/25 ml single-dose viils for doxorubicin hydrochloride liposome injection.
This drug is used in the treatment of ovarian cancer, Aids-Related Kaposis Sarcoma and Multiple Myeloma. According to IQVIA, the market of this drug is $ 29 million for 12 months by March 2025. With this approval, Alembic now has 224 anda approvals from USFDA, including 201 finals and 23 tental approvals.
Company condition
The shares of Alembic Pharmaceuticals are trading above its 5, 10, 20, 30, 50, 100, 150 and 200-days average price, which shows strong trends. Its RSI is 74.41, that is, the stock is slightly overbott. According to BSE, P/E ratio is 34.36 and P/B value is 4.30. The company’s EPS is 32.03 and Roe is 12.51%, which indicates a fine performance. According to the trendline, beta is 0.46, meaning the share fluctuations are low. As of March 2025, promoters have 69.67% stake, which shows their strong confidence in the company.
Market dropped after 4 days of climbing
Today, after 4 days of rise in the stock market, selling is being seen today. In the last trading session, the market’s major index Sensex and Nifty had closed up by 3 percent. Today, the Indian market is trading at 83,538.43 with a decline of about 520.47 points. About 20 companies of Sensex are seeing a decline. Whereas only and only 11 have gained momentum.